☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Ocuphire Pharma
Ocuphire Pharma to Acquire Opus Genetics
October 23, 2024
Ocuphire Pharma Signs an Exclusive License Agreement with FamyGen for Nyxol Eye Drops to Treat Reversal of Mydriasis, Presbyopia a...
November 9, 2022
Load more...
Back to Home
Modal title
×
Modal body text goes here.
